bet 291
Whitecaps up for sale, could approach $500 millionDORTMUND, Germany (Reuters) -Substitute Ferran Torres scored twice including an 85th-minute winner as Barcelona earned a hard-fought 3-2 victory at Borussia Dortmund in the Champions League on Wednesday to move to the brink of qualification. In a pulsating five-goal second half, Torres struck twice in 10 minutes after coming on in the 71st minute to lift Barcelona to 15 points, in second place with two games remaining in the league phase. Dortmund twice came from a goal down with Serhou Guirassy scoring both goals but they could not do it a third time after Torres grabbed his second after being teed up by Lamine Yamal. The Germans dropped to ninth in the standings on 12 points, with the top eight earning automatic qualification to the round of 16. “We can be very happy with what we have done,” Barca coach Hansi Flick told reporters. “The first half was wonderful and in the second half, when they scored, we remained calm and solid. “Dortmund played very well with players who have a high pace but we did it well. We conceded goals because of mistakes we made. We can always improve, but today I have to say congratulations to the team because they did it really well,” he said. Barcelona bossed possession from the start and captain Raphinha and top scorer Robert Lewandowski had early chances. The hosts responded with an opportunity of their own through Marcel Sabitzer but it was Dortmund keeper Gregor Kobel who was kept busy in a largely one-sided first half as the visitors enjoyed close to 70% possession. Dortmund looked sharper after the break and Guirassy put the ball in the net in the 50th minute before the effort was ruled out for offside. There was nothing wrong, however, when Raphinha latched on to a superb Dani Olmo pass to finish off a quick move in the 53rd minute and put Barcelona in the driving seat with his sixth goal of the competition. The hosts levelled through Guirassy’s well-taken penalty on the hour after the Guinea international was brought down in the box before Dortmund’s Kobel came to the rescue once more, stopping another Olmo shot. He was beaten in the 75th when Torres, who had come on four minutes earlier, slotted in on the rebound after Kobel had punched a Frenkie de Jong volley into his path. Guirassy hit back three minutes later when the Barca defence was caught napping but it was not enough to earn a point as Torres scored again after a superb through ball from Yamal. There was more bad news for injury-plagued Dortmund after defender Nico Schlotterbeck turned his ankle following a header in the last move of the game and had to be carried off on a stretcher after the final whistle. (Reporting by Karolos Grohmann,Editing by Toby Davis and Ed Osmond) Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibility for its content. var ytflag = 0;var myListener = function() {document.removeEventListener('mousemove', myListener, false);lazyloadmyframes();};document.addEventListener('mousemove', myListener, false);window.addEventListener('scroll', function() {if (ytflag == 0) {lazyloadmyframes();ytflag = 1;}});function lazyloadmyframes() {var ytv = document.getElementsByClassName("klazyiframe");for (var i = 0; i < ytv.length; i++) {ytv[i].src = ytv[i].getAttribute('data-src');}} Save my name, email, and website in this browser for the next time I comment. Δ document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() );
Pre-Money Valuation of JPY9 Billion is Approximately Multiples of Current Parent Company Market Capitalization. Strategic Investors Further Validation of Technology and Growth Potential. Further Commercialization with Recent 25,000 Unit Order from B2B Sales Channel. TOKYO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) announces that its subsidiary MEDIROM MOTHER Labs Inc. raised to date an aggregate total of 260.3 million yen (approximtaely USD $ [1.7] million calculated at an exchange rate of JPY[153.64] to US$1) at a pre-money equity valuation of JPY9 billion (approximately USD $ [58.6] million calculated at an exchange rate of JPY[153.64] to US$1) in its Series A equity financing. NFES Technologies Inc. is the lead investor in the financing round, and several public companies in Japan, including M3, Inc. (TOKYO PRIME: 2413) and Elematec Corporation (TOKYO PRIME: 2715), as well as certain individual investors are also participating. The Series A equity financing round is still ongoing. MEDIROM MOTHER Labs has closed financings with six investors to date and intends to conclude the financing round by December 31, 2024. “We are very excited that our MEDIROM MOTHER Labs subsidiary has received such significant validation from strategic partners as our lead investor NFES Technologies Inc. as well as M3,Inc and Elematec Corporation. The pre money valuation of 9 billion yen is approximately multiples of MEDIROM’s current NASDAQ listing market capitalization which I believe further validates our technology, business model and growth potential.” said Kouji. The MOTHER Bracelet® is currently in commercialization. From July 1, 2024 through October 31, 2024, MEDIROM MOTHER Labs received purchase orders for an aggregate of over 25,000 units from its B2B sales channel. “We believe the MOTHER Bracelet® to be the world’s first fitness tracker that requires no electric charging by utilizing an innovative technology that enables the user’s body heat to generate electricity. We co-developed it with Matrix Industries, based in Silicon Valley and believe its features are cutting-edge technology with rich features and ease of use to track fitness levels, sleep patterns, pulse and body temperature We will continue to target markets such as hospitals, nursing homes and gyms, where such data is vital,” said Yoshio Uekusa, CEO of MEDIROM MOTHER Labs. ABOUT MEDIROM MOTHER Labs Inc. A subsidiary of MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”), MEDIROM Mother Labs Inc. focuses on the health-tech sector. The company’s core activities include the "Specific Health Guidance Program" offered through the "Lav" health application and development and sales of the 24/7 recharge-free MOTHER Bracelet®︎ smart tracker. By leveraging the features of the recharge-free MOTHER Bracelet®︎, MOTHER Labs offers customizable health management solutions across diverse sectors, including caregiving, logistics, manufacturing, and similar industries. Forward-Looking Statements Regarding MEDIROM and MOTHER Labs Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about MEDIROM’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to MEDIROM’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause MEDIROM’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond MEDIROM’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects MEDIROM’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to MEDIROM’s operations, results of operations, growth strategy and liquidity. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward-looking statements in this press release include: MEDIROM’s ability to achieve its development goals for its business and execute and evolve its growth strategies, priorities and initiatives; MEDIROM Mother Labs’s ability to close its Series A equity financing on the anticipated timeline or at all; MEDIROM’s ability to collaborate in the anticipated manner; changes in Japanese and global economic conditions and financial markets, including their effects on MEDIROM’s expansion in Japan and certain overseas markets; MEDIROM’s ability to increase sales of the MOTHER Bracelet and achieve and sustain profitability in its Digital Preventative Healthcare Segment; the fluctuation of foreign exchange rates, which affects MEDIROM’s expenses and liabilities payable in foreign currencies; MEDIROM’s ability to maintain and enhance the value of its brands and to enforce and maintain its trademarks and protect its other intellectual property; MEDIROM’s ability to raise additional capital on acceptable terms or at all; MEDIROM’s level of indebtedness and potential restrictions on MEDIROM under MEDIROM’s debt instruments; changes in consumer preferences and MEDIROM’s competitive environment; MEDIROM’s ability to respond to natural disasters, such as earthquakes and tsunamis, and to global pandemics, such as COVID-19; and the regulatory environment in which MEDIROM operates. More information on these risks and other potential factors that could affect MEDIROM’s business, reputation, results of operations, financial condition, and stock price is included in MEDIROM’s filings with the Securities and Exchange Commission (the “SEC”), including in the “Risk Factors” and “Operating and Financial Review and Prospects” sections of MEDIROM’s most recently filed periodic report on Form 20-F and subsequent filings, which are available on the SEC website at www.sec.gov . MEDIROM assumes no obligation to update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ from those anticipated in these forward-looking statements, even if new information becomes available in the future. MEDIROM Healthcare Technologies Inc. NASDAQ Symbol: MRM Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan Web https://medirom.co.jp/en Contact: ir@medirom.co.jp MEDIROM MOTHER Labs Inc. Tradepia Odaiba, 2-3-1 Daiba, Minato-ku, Tokyo, Japan For more information visit: https://mother-bracelet.com
Great Plains Communications secures $500 million in financing
NoneChina's getting a big electric car battery swapping boost in 2025. Would that work across the globe?
Pb’s forest cover shrinks, but tree cover growsThese cutting-edge gadgets make for the perfect holiday gifts, offering high-quality technology at an affordable price point. The PB X-116 Fast Power bank available for INR 2499/-, is a must-have accessory for the busy traveler or anyone on-the-go this festive season. With fast-charging technology, this compact power bank ensures that smartphones, tablets, and other USB-powered devices stay powered up throughout the day—whether you're shopping, traveling, or capturing holiday memories. Its sleek design and efficient performance make it an essential tech companion for modern users. Available at: https://ubonindia.com/ products/pb-x116-22-5w-5-in-1- power-bank-boast-of-fast- charging-built-in-cables For music lovers, the CL-120 Earphones, available for INR 1599/- provide the perfect balance of sound quality and comfort. Designed for immersive audio experiences, these earphones feature crisp, clear sound that enhances every moment. Whether it's enjoying holiday music, taking calls, or watching your favourite festive shows, the CL-120 offers a premium audio experience with a stylish and durable design. It’s an ideal gift for anyone who values both quality and convenience in their audio gear. Available at: https://ubonindia.com/ products/ubon-cl-120-enc- magnetic-wireless-neckband- enjoy-powerful-features-with- 80-hours-playtime-for- ultimate-audio-enjoyment? srsltid= AfmBOoo4FH7fVe1UMoWtq4Hqb5JFR9 LyW-ZWGoUB51Yh67VdAMs29LuU “We are delighted to bring our customers two of our finest products this Christmas,” said Mandeep Arora, Director of UBON. “The PB X-116 Fast Power bank and CL-120 Earphones combine innovation with practicality, making them the ideal gifts to make anyone's holiday season a little brighter.” Both products are available for purchase via UBON’s official website and leading online retail platforms, with additional festive discounts and offers to provide customers with even greater value. These products reflect UBON’s commitment to offering high-performance, affordable solutions for all tech enthusiasts. This Christmas, gift the power of innovation and technology with UBON’s PB X-116 Fast Powerbank and CL-120 Earphones—thoughtful, functional, and stylish gifts for everyone on your list. Both products will be available at UBON’s website and authorised retail outlets across India. TAGS: UBONSANTA CLARA, Calif. , Dec. 13, 2024 /PRNewswire/ -- Marvell Technology, Inc. (NASDAQ: MRVL), today announced a quarterly dividend of $0.06 per share of common stock payable on January 30, 2025 to shareholders of record as of January 10, 2025 . About Marvell To deliver the data infrastructure technology that connects the world, we're building solutions on the most powerful foundation: our partnerships with our customers. Trusted by the world's leading technology companies for over 25 years, we move, store, process and secure the world's data with semiconductor solutions designed for our customers' current needs and future ambitions. Through a process of deep collaboration and transparency, we're ultimately changing the way tomorrow's enterprise, cloud, automotive, and carrier architectures transform—for the better. Marvell® and the Marvell logo are registered trademarks of Marvell and/or its affiliates. For further information, contact: Ashish Saran Senior Vice President, Investor Relations 408-222-0777 ir@marvell.com View original content to download multimedia: https://www.prnewswire.com/news-releases/marvell-technology-inc-declares-quarterly-dividend-payment-302331636.html SOURCE Marvell
NoneBuckle, Destination XL, Pyxis Tankers set to report earnings Friday
CVB financial director Stephen A. Del Guercio sells $197,279 in stock
Fifteen years ago I about a different SQUID. Here’s an : Fleeing drivers are a common problem for law enforcement. They just won’t stop unless persuaded—persuaded by bullets, barriers, spikes, or snares. Each option is risky business. Shooting up a fugitive’s car is one possibility. But what if children or hostages are in it? Lay down barriers, and the driver might swerve into a school bus. Spike his tires, and he might fishtail into a van—if the spikes stop him at all. Existing traps, made from elastic, may halt a Hyundai, but they’re no match for a Hummer. In addition, officers put themselves at risk of being run down while setting up the traps. But what if an officer could lay down a road trap in seconds, then activate it from a nearby hiding place? What if—like sea monsters of ancient lore—the trap could reach up from below to ensnare anything from a MINI Cooper to a Ford Expedition? What if this trap were as small as a spare tire, as light as a tire jack, and cost under a grand? Thanks to imaginative design and engineering funded by the Small Business Innovation Research (SBIR) Office of the U. S. Department of Homeland Security’s Science and Technology Directorate (S&T), such a trap may be stopping brigands by 2010. It’s called the Safe Quick Undercarriage Immobilization Device, or SQUID. When closed, the current prototype resembles a cheese wheel full of holes. When open (deployed), it becomes a mass of tentacles entangling the axles. By stopping the axles instead of the wheels, SQUID may change how fleeing drivers are, quite literally, caught. •
Trump appoints ‘AI and crypto czar’Gus Atkinson hat-trick puts England in command of second Test in New Zealand